FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls

benzinga.com/news/fda/25/06/46175777/fda-flags-major-safety-concerns-for-argenxs-nerve-disorder-drug-stock-falls

Argenx SE (NASDAQ:ARGX) stock is trading lower on Monday after the U.S. Food and Drug Administration (FDA) signaled serious risks/safety identified by the reporting system for Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase).
The FDA highlighted the severe worsening of chronic…

This story appeared on benzinga.com, 2025-06-30 17:13:32.
The Entire Business World on a Single Page. Free to Use →